Medicine and Dentistry
Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
Progesterone Receptor
58%
Membrane Component
58%
Patient
50%
Neoplasm
33%
Epidermal Growth Factor Receptor Kinase Inhibitor
33%
Therapeutic Procedure
33%
Cancer Cell
33%
Combination Therapy
16%
Cell Proliferation
16%
Ligand
16%
Protein
16%
Chemotherapeutic Agent
16%
Drug
16%
Side Effect
16%
Chemotherapy
16%
Drive
8%
In Vitro
8%
Gene Expression
8%
Development
8%
Erlotinib
8%
Membrane
8%
Cholesterol
8%
Cancer Therapy
8%
Protein Tyrosine Kinase
8%
Vasculotropin
8%
Antibody
8%
Cancer Mortality
8%
Lung Tumor
8%
Tumor
8%
Gefitinib
8%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
Progesterone Receptor
58%
Neoplasm
41%
Epidermal Growth Factor Receptor Kinase Inhibitor
33%
Drug
16%
Ligand
16%
Protein
16%
Side Effect
16%
Erlotinib
8%
Gefitinib
8%
Protein Tyrosine Kinase
8%
Antibody
8%
Cholesterol
8%
Cancer Mortality
8%
Lung Tumor
8%
Vasculotropin
8%
Cell Proliferation
8%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Membrane Component
50%
Progesterone Receptor
50%
Cancer Cell
28%
Growth Factor Receptor Inhibitor
28%
Protein
14%
Cell Proliferation
14%
Gefitinib
7%
Radiation
7%
Tyrosine Kinase
7%
Membrane
7%
Cancer Mortality
7%
Sample
7%
Development
7%
Antibody
7%
Erlotinib
7%
Drive
7%
Gene Expression
7%
Cholesterol
7%
Small Molecule
7%
Vascular Endothelial Growth Factor
7%